• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-ASD-009
Device Problem Device Dislodged or Dislocated (2923)
Patient Problems Dyspnea (1816); Embolism (1829); Tachycardia (2095)
Event Date 04/21/2015
Event Type  Injury  
Event Description
The atrial septal defect measured 6.2mm in length via tee.Initially, a 7mm amplatzer septal occluder (aso) was attempted but after it fell into the defect and into the left atrium, the 7mm aso was removed as it remained attached to the delivery cable.Next, a 9mm aso was successfully deployed without issue.Five and a half hours post-procedure, the patient became dyspneic and had sinus tachycardia.The patient was diagnosed with hyperventilation syndrome and the patient improved with breathing maneuvers, returning her to a normal heart rate.An angiography then revealed the aso had embolized to the left common iliac artery.A 12f sheath was delivered via the left femoral artery and the 9mm aso was percutaneously removed using a gooseneck snare.The patient was discharged without any complications.The physician may reattempt percutaneous closure in the future.
 
Manufacturer Narrative
(b)(4).The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.The review determined the process was performed and completed in accordance with sjm specifications and procedures.The results of the investigation are inconclusive since the device was not returned for analysis.Our investigation was limited to the review of the device history record, which showed that each manufacturing and inspection operation was performed and indicated complete in accordance with sjm specifications and procedures.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key4803090
MDR Text Key21842319
Report Number2135147-2015-00054
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 05/07/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/28/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Expiration Date05/31/2019
Device Model Number9-ASD-009
Device Catalogue Number9-ASD-009
Device Lot Number4680787
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/07/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/16/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-